切换至 "中华医学电子期刊资源库"

中华腔镜泌尿外科杂志(电子版) ›› 2025, Vol. 19 ›› Issue (02) : 251 -254. doi: 10.3877/cma.j.issn.1674-3253.2025.02.022

病例报告

腹膜后单中心型Castleman病一例并文献复习
何海填1,(), 罗锦斌1, 汪洋1, 张斌1, 王可兵1   
  1. 1. 518000 广东,深圳市前海蛇口自贸区医院泌尿外科
  • 收稿日期:2023-08-02 出版日期:2025-04-01
  • 通信作者: 何海填

A case report of unicentric Castleman disease in the retroperitoneum and literature review

Haitian He1,(), Jinbin Luo1, Yang Wang1, Bin Zhang1, Kebing Wang1   

  1. 1. Department of Urology,Qianhai Shekou Free Trade Zone Hospital,Shenzhen,518000,China
  • Received:2023-08-02 Published:2025-04-01
  • Corresponding author: Haitian He
引用本文:

何海填, 罗锦斌, 汪洋, 张斌, 王可兵. 腹膜后单中心型Castleman病一例并文献复习[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(02): 251-254.

Haitian He, Jinbin Luo, Yang Wang, Bin Zhang, Kebing Wang. A case report of unicentric Castleman disease in the retroperitoneum and literature review[J/OL]. Chinese Journal of Endourology(Electronic Edition), 2025, 19(02): 251-254.

本文报道1 例术前诊断未明的腹膜后占位病例,患者同时合并高血压病,被怀疑为副神经节瘤,通过腹腔镜切除腹膜后占位,患者术后病理诊断为Castleman 病,最终患者治愈出院。结合文献,本文进一步讨论Castleman 病的特点、临床表现及治疗方法。

This report presents a case of a retroperitoneal mass with an undetermined preoperative diagnosis,where the patient also had hypertension and was suspected of paraganglioma.We performed a laparoscopic resection of the retroperitoneal mass,the pathological diagnosis confirmed Castleman disease.The patient was successfully discharged after treatment.In conjunction with literature review,we further discuss the characteristics,clinical manifestations,and treatment approaches for Castleman disease.

图1 Castleman 病患者术前上腹部增强CT 平扫 图2 Castleman 患者肿瘤免疫组化结果 注:1a 为横断面,1b 为冠状面,箭头示肿瘤;2a 示CD3(+),2b 示CD10 生发中心(+),HE×20
[1]
郑永江,赖文兴,李旭东,等.Castleman 病8 例临床分析[J].热带医学杂志,2012,12(9): 1103-1105.Zheng YJ,Lai WX,Li XD,et al.The clinical analysis of eight cases of Castleman disease[J].J Trop Med,2012,12(9): 1103-1105.
[2]
Castleman B,Towne VW.Case records of the Massachusetts General Hospital,weekly clinicopathological exercises,founded by Richard C.Cabot[J].New Eng J Med,1954,251(10):396-400.
[3]
Jones DJ,Marino M,Bohmer R.Castleman's disease: a rare cause for a symptomatic retroperitoneal mass[J].ANZ J Surg,2022,92(3):555-556.DOI: 10.1111/ans.17059.
[4]
van Rhee F,Oksenhendler E,Srkalovic G,et al.International evidence-based consen-sus diagnostic and treatment guidelines for unicentric Castleman disease[J].Blood Adv,2020,4(23): 6039-6050.DOI: 10.1182/bloodadvances.2020003334.
[5]
Paparella MT,Popolizio T,Grasso D,et al.Castleman disease: a rare case in a young woman[J].Acta Biomed,2023,94(S1): e2023058.DOI: 10.23750/abm.v94iS1.13795.
[6]
余浩源,惠卉,上官思雨,等.自体干细胞移植治疗以Castleman病为表现的POEMS 综合征1 例报道并文献复习[J].徐州医科大学学报,2023,43(9): 689-692.DOI: 10.3969/j.issn.2096-3882.2023.09.012.Yu HY,(Xi/Hui) H,Shangguan SY,et al.Autologous stem cell transplantation for the treatment of POEMS syndrome manifested by Castleman's disease: a case report and literature review[J].J Xuzhou Med Univ,2023,43(9): 689-692.DOI: 10.3969/j.issn.2096-3882.2023.09.012.
[7]
Yin Y,Yu T,Mulmi Shrestha S.Unicentric Castleman's disease of hepatic hilum and retroperitoneum: a case report for endoscopic ultrasonography differential diagnosis and a literature review[J].Clin J Gastroenterol,2021,14(4): 1250-1254.DOI: 10.1007/s12328-021-01418-2.
[8]
杜春萍,沈诚,周渝斌,等.肺门型Castleman 病4 例报告[J].四川大学学报(医学版),2012,43(6): 952-954.DOI: 10.13464/j.scuxbyxb.2012.06.014.Du CP,Shen C,Zhou YB,et al.Pulmonary hilum castleman's disease: a report of 4 cases and review of literature[J].J Sichuan Univ Med Sci Ed,2012,43(6): 952-954.DOI: 10.13464/j.scuxbyxb.2012.06.014.
[9]
Kitakaze M,Miyoshi N,Fujino S,et al.Surgical resection for pelvic retroperitoneal Castleman's disease: a case report and review literature[J].Biomed Rep,2021,14(3): 29.DOI: 10.3892/br.2021.1405.
[10]
Buntic N,Brown T,Nisar US,et al.Unicentric castleman's disease presenting As back pain[J].Cureus,2022,14(12): e32219.DOI:10.7759/cureus.32219.
[11]
Nagano S,Yokouchi M,Yamamoto T,et al.Castleman's disease in the retroperitoneal space mimicking a paraspinal schwannoma: a case report[J].World J Surg Oncol,2013,11: 108.DOI: 10.1186/1477-7819-11-108.
[12]
刘书颖,张志华.以肾功能损伤为主要表现的Castleman 病的诊断及治疗(附1 例分析)[J].山东医药,2022,62(9): 92-95.DOI:10.3969/j.issn.1002-266X.2022.09.022.Liu SY,Zhang ZH.Diagnosis and treatment of Castleman disease manifested primarily by renal function impairment: a case analysis[J].Shandong Med J,2022,62(9): 92-95.DOI: 10.3969/j.issn.1002-266X.2022.09.022.
[13]
韩鸿雁,李晓兵,张博,等.Castleman 病临床病理分析并文献复习[J].临床与实验病理学杂志,2015,31(1): 58-61.DOI:10.13315/j.cnki.cjcep.2015.01.015.Han HY,Li XB,Zhang B,et al.Clinicopathologic analyses of Castleman's disease and review of the literature[J].Chin J Clin Exp Pathol,2015,31(1): 58-61.DOI: 10.13315/j.cnki.cjcep.2015.01.015.
[14]
Aguilar-Rodriguez R,Milea SL,Demirci I,et al.Localized retroperitoneal castleman's disease: a case report and review of the literature[J].J Med Case Rep,2014,8: 93.DOI: 10.1186/1752-1947-8-93.
[15]
Singh R,Prasher R,Mohan S,et al.Retroperitoneal unicentric Castleman's disease-a case report and review of literature[J].Int J Surg Case Rep,2021,86: 106325.DOI: 10.1016/j.ijscr.2021.106325.
[16]
杨柳青,葛晓东,谢明汛,等.单中心型Castleman 病23 例CT影像分析[J].肿瘤学杂志,2022,28(11): 963-967.DOI: 10.11735/j.issn.1671-170X.2022.11.B013.Yang LQ,Ge XD,Xie MX,et al.CT imaging features analysis of 23 cases with unicentric castleman disease[J].J Chin Oncol,2022,28(11): 963-967.DOI: 10.11735/j.issn.1671-170X.2022.11.B013.
[17]
孙侠,张蔚,赵石磊,等.腹膜后单中心型Castleman 病的CT 表现及其强化特征分析[J].国际医学放射学杂志,2021,44(3): 341-345.DOI: 10.19300/j.2021.L18618.Sun X,Zhang W,Zhao SL,et al.CT findings and enhancement characteristics of retroperitoneal unicentric Castleman's disease[J].Int J Med Radiol,2021,44(3): 341-345.DOI: 10.19300/j.2021.L18618.
[18]
卢瞳,居胜红.腹膜后副神经节瘤的影像学诊断与鉴别诊断[J].中华放射学杂志,2020,10: 1033-1037.DOI: 10.3760/cma.j.cn112149-20200608-00789 Lu T,Ju SH.Imaging diagnosis and differential diagnosis of retroperitoneal paragangli-omas[J].Chin J Radiol,2020,10:1033-1037.DOI: 10.3760/cma.j.cn112149-20200608-00789
[19]
Lugo-Fagundo E,Lugo-Fagundo C,Weisberg EM,et al.CT of Castleman disease in the mediastinum[J].Radiol Case Rep,2023,18(3): 1161-1163.DOI: 10.1016/j.radcr.2022.12.054.
[20]
Sun X,Du Y,Zhang Y,et al.Unicentric Castleman disease:multidetector computed tomography classification with surgical and pathologic correlation[J].Quant Imaging Med Surg,2021,11(8):3562-3568.DOI: 10.21037/qims-20-1033.
[21]
中华医学会血液学分会淋巴细胞疾病学组,中国抗癌协会血液肿瘤专业委员会,中国Castleman 病协作组.中国Castleman 病诊断与治疗专家共识(2021 年版)[J].中华血液学杂志,2021,42(7):529-534.DOI: 10.3760/cma.j.issn.0253-2727.2021.07.001.Hematology Committee of Chinese Medical Association,Hematological Oncology Committee of China Anti-Cancer Association,China Castleman Disease Network (CCDN).The consensus of the diagnosis and treatment of Castleman disease in Chi-na(2021)[J].Chin J Hematol,2021,42(7): 529-534.DOI:10.3760/cma.j.issn.0253-2727.2021.07.001.
[22]
van Rhee F,Oksenhendler E,Srkalovic G,et al.International evidence-based con-sensus diagnostic and treatment guidelines for unicentric Castleman disease[J].Blood Adv,2020,4(23): 6039-6050.DOI: 10.1182/bloodadvances.2020003334.
[23]
Talat N,Belgaumkar AP,Schulte KM.Surgery in castleman's disease:a systematic review of 404 published cases[J].Ann Surg,2012,255(4): 677-684.DOI: 10.1097/SLA.0b013e318249dcdc.
[24]
Molacek J,Treska V,Skalicky T,et al.Unicentric form of Castleman's disease,pitfalls of diagnosis and surgical treatment[J].Front Oncol,2023,13: 1057683.DOI: 10.3389/fonc.2023.1057683.
[1] 吴楚营, 叶凯. 不同部位胃肠道间质瘤的腹腔镜手术策略[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(02): 224-227.
[2] 杨培容, 潘刚, 周春霞. 胰腺癌术后胰瘘的危险因素及治疗进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(02): 228-230.
[3] 邱皓炜, 徐臻, 肖泽秀, 夏燕, 查高峰, 庞俊. 前列腺癌mRNA 疫苗研究进展[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(02): 134-139.
[4] 刘咏博, 郭佳. 外泌体在前列腺癌细胞免疫逃逸中的研究进展[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(02): 140-145.
[5] 董振阳, 瞿旻, 王燕, 张韻, 高旭. 序贯多学科会诊模式在前列腺癌全程管理中的应用[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(02): 152-158.
[6] 万颂, 刘璇, 黄源兴, 江文聪, 周宇林, 习明. 胆固醇生物合成相关基因对前列腺癌预后和治疗的意义[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(02): 205-215.
[7] 潘麒文, 何立儒. 前列腺癌放射治疗前沿进展荟萃[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(02): 279-279.
[8] 刘康寿, 曹明溶, 孙健. 钇90选择性内放射治疗肝内胆管癌的现状与展望[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 197-202.
[9] 陈博滔, 胡宽, 毛先海. 胆囊癌肿瘤微环境与系统治疗[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 203-208.
[10] 吴春霖, 侯一夫, 陈凯, 赵冀, 唐世杰, 杨洪吉. 肝动脉灌注化疗联合PD-1/TKI 治疗不可切除性肝癌的安全性和疗效[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 217-224.
[11] 曾士桃, 严庆, 廖珊, 陈焕伟. 肝动脉灌注化疗联合仑伐替尼及PD-1抑制剂与肝动脉灌注化疗联合仑伐替尼治疗不可切除肝癌的疗效比较[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 225-231.
[12] 杨陈凤麟, 张潇, 丁洁茹, 胡文, 李尧, 陈品初, 王泽桐, 张起帆. 转化治疗后肝癌肝切除患者术后自发性胆漏发生原因初步探讨[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 256-261.
[13] 颜军, 郭诗翔, 吴堃. 新辅助治疗后“二步法”改良Appleby 术治疗局部进展期胰体癌[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 274-280.
[14] 王重阳, 滑文文, 魏丽, 邱应和, 杨发才, 李函娟. 免疫治疗联合局部区域疗法治疗中晚期肝癌的研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 302-307.
[15] 潘佰猛, 张挽乾, 张秋雨, 曹芮, 李鹏, 张维桢, 张灵强. 肝血管瘤临床治疗进展[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 308-313.
阅读次数
全文


摘要